Definitions and Standards

by

1. Purpose

This section establishes the terminology and analytical standards used throughout the document.

Clear definitions reduce ambiguity, maintain internal consistency across Parts I–V, and support accurate interpretation of ecological, immunological, and metabolic findings.

—

2. Terminology for Ecological States

2.1 Functional Ecosystem

A microbial configuration in which anaerobic guilds, mucin-supporting taxa, and fermentation pathways form a stable, resilient metabolic network.

2.2 Disturbed Ecosystem

A system exhibiting temporary imbalance without evidence of structural collapse.

Reversible through spontaneous re-equilibration or modest intervention.

2.3 Collapsed Ecosystem

A system in which:

  • anaerobic keystone guilds fall below functional thresholds,
  • oxygen-tolerant taxa gain structural dominance, and
  • feedback loops prevent spontaneous recovery.

    • This condition anchors the analysis in Parts I and II.

    2.4 Pathogenic Steady State

    A self-reinforcing microbial configuration dominated by pathobionts, characterized by metabolic rigidity, barrier stress, and persistent antigen flux.

    This term describes the stable configuration observed by 2024–2025.

    —

    3. Terminology for Intervention Architecture

    3.1 Layer

    A mechanistic function or role required in a given ecological state (e.g., biofilm disruption, binding of metabolites, barrier reconstruction).

    3.2 Mechanism

    The biological process by which a layer role is achieved.

    3.3 Agent

    Any intervention—nutrient, peptide, binder, supplement—chosen to instantiate a mechanism.

    3.4 Gate

    A structured sequence of layers deployed under defined timing and interaction constraints.

    Gates constitute the intervention architecture in Part III.

    3.5 Unfilled Role

    A layer goal not addressed by selected interventions.

    Unfilled roles are documented for transparency.

    —

    4. Terminology for Barrier and Physiology

    4.1 Barrier

    The combined function of mucus layer, epithelial layer, and immune interactions at the luminal surface.

    4.2 Permeability

    The degree of antigen, metabolite, and endotoxin flux across the epithelial layer.

    Measured functionally rather than symptomatically.

    4.3 Motility

    Coordinated propulsion and migrating motor complex (MMC) function that maintains compartmentalization.

    4.4 Mucin Layer

    The mucus matrix supported by goblet cells; central to microbial spatial organization and epithelial protection.

    4.5 Gastric Acid Function

    Parietal cell output required for protein digestion, mineral solubilization, and upstream microbial control.

    —

    5. Terminology for Immune Architecture

    5.1 Innate Signaling

    TLR- and PRR-driven detection of microbial products, particularly LPS and other pathobiont-associated patterns.

    5.2 Adaptive Activation

    T- and B-cell processes integrating antigen load, cytokine tone, and tissue-specific responses.

    5.3 Cholinergic Anti-Inflammatory Pathway

    Vagal-mediated modulation of inflammatory signaling, relevant to neuro-immune interactions.

    —

    6. Evidence Standards

    6.1 Evidence Hierarchy

  • Human clinical data: prioritized when directly relevant to the mechanisms under discussion.
  • Animal models: used where human data are absent or incomplete and mechanisms are conserved.
  • In vitro / mechanistic studies: used to clarify pathways and interactions.
  • Inferences: explicitly identified and limited to plausible extensions of established mechanisms.

    • 6.2 Transparency Requirements

  • All assumptions marked as such.
  • All references tied to specific mechanisms or data patterns.
  • Unsupported speculation excluded.

    • —

    7. Analytical Standards

    7.1 System-Level Interpretation

    Findings are interpreted in terms of ecological flows, constraints, and feedback loops rather than isolated taxa or biomarkers.

    7.2 Temporal Coherence

    Data and clinical events are analyzed in chronological context to identify inflection points, stabilizing phases, and collapse trajectories.

    7.3 Interaction Mapping

    Mechanistic chapters document interactions across microbiome, barrier, immune, metabolic, and neuroenteric domains.

    Single-domain explanations are avoided where systems interactions are evident.

    7.4 Intervention Logic

    Gate sequencing reflects:

  • mechanism timing windows,
  • inter-layer compatibility,
  • metabolic and inflammatory load,
  • and the structural requirements for shifting a collapsed ecosystem out of a pathogenic steady state.

    • —

    8. Naming Conventions

  • Chapters named by function, not by method.
  • Sections avoid interrogative titles (“what,” “why,” “how”).
  • Terms used consistently across the document.
  • Cross-references use relative paths to support MkDocs site navigation.

    • —

    9. Revision Standards

    Updates occur when:

  • new metagenomic or clinical data become available,
  • mechanistic clarity improves,
  • or structural adjustments are required to maintain cohesion.

    • Version histories are documented in FM-03.